Literature DB >> 8084536

Serotonin 1A-receptor activation suppresses respiratory apneusis in the cat.

P M Lalley1, A M Bischoff, D W Richter.   

Abstract

Malfunction of inhibitory synaptic processes in the brainstem result in abnormal prolonged inspiration (apneusis). Since we previously found that the serotonin (5-hydroxytryptamine; 5-HT) 5-HT1A receptor agonist 8-hydroxy-dipropylaminotetralin (8-OH-DPAT) shortens inspiratory discharges, we tested its ability to suppress apneusis. We recorded phrenic nerve activity and the membrane potential of medullary expiratory (E-2) and postinspiratory (PI) neurons in 14 anaesthetized, paralyzed, artificially ventilated cats. Systemic hypoxia or i.v. injection of pentobarbital sodium or the N-methyl-D-aspartate (NMDA) receptor blocker ketamine induced apneustic phrenic nerve discharges, delayed depolarization to threshold of E-2 neurons and prolonged hyperpolarization in PI neurons. 8-OH-DPAT (10-40 micrograms/kg i.v.) produced partial to complete restoration of normal phrenic nerve discharges and membrane potential.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084536     DOI: 10.1016/0304-3940(94)90662-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Recent insights into hyperventilation from the study of Rett syndrome.

Authors:  A M Kerr; P O Julu
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Respiratory rhythm generation in vivo.

Authors:  Diethelm W Richter; Jeffrey C Smith
Journal:  Physiology (Bethesda)       Date:  2014-01

3.  Blockade of synaptic inhibition within the pre-Bötzinger complex in the cat suppresses respiratory rhythm generation in vivo.

Authors:  O Pierrefiche; S W Schwarzacher; A M Bischoff; D W Richter
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

Review 4.  The role of serotonin in respiratory function and dysfunction.

Authors:  Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

Review 5.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

6.  Time- and dose-related effects of three 5-HT receptor ligands on the genioglossus activity in anesthetized and conscious rats.

Authors:  S Besnard; F Massé; M Verdaguer; B Cappelin; J C Meurice; C Gestreau
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

7.  Raphé neurons stimulate respiratory circuit activity by multiple mechanisms via endogenously released serotonin and substance P.

Authors:  Krzysztof Ptak; Tadashi Yamanishi; Jason Aungst; Lorin S Milescu; Ruli Zhang; George B Richerson; Jeffrey C Smith
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

8.  Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains.

Authors:  Motoo Yamauchi; Jesse Dostal; Hiroshi Kimura; Kingman P Strohl
Journal:  J Appl Physiol (1985)       Date:  2008-05-29

Review 9.  Countermeasures for Preventing and Treating Opioid Overdose.

Authors:  Charles P France; Gerard P Ahern; Saadyah Averick; Alex Disney; Heather A Enright; Babak Esmaeli-Azad; Arianna Federico; Lisa R Gerak; Stephen M Husbands; Benedict Kolber; Edmond Y Lau; Victoria Lao; David R Maguire; Michael A Malfatti; Girardo Martinez; Brian P Mayer; Marco Pravetoni; Niaz Sahibzada; Phil Skolnick; Evan Y Snyder; Nestor Tomycz; Carlos A Valdez; Jim Zapf
Journal:  Clin Pharmacol Ther       Date:  2020-11-29       Impact factor: 6.875

Review 10.  [Serotonin receptor 1A-modulated dephosphorylation of glycine receptor α3: a new molecular mechanism of breathing control for compensation of opioid-induced respiratory depression without loss of analgesia].

Authors:  T Manzke; M Niebert; U R Koch; A Caley; S Vogelgesang; A-M Bischoff; S Hülsmann; E Ponimaskin; U Müller; T G Smart; R J Harvey; D W Richter
Journal:  Schmerz       Date:  2011-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.